ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection

NCT06439433 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia Grade 2
Papillomavirus Infections
p16 Protein

Interventions

DRUG: Aminolaevulinic acid (500-mg bottle)
DRUG: Aminolaevulinic acid (750-mg bottle)
DRUG: Placebo

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.